Literature DB >> 1734224

Benign cystic mesothelioma of the peritoneum: the occurrence of an adult entity in a child.

A Hanukoglu1, G Gewurtz, L Zaidel, M Krispin, D Fried.   

Abstract

Benign cystic mesothelioma of the peritoneum is considered a disease of adulthood occurring predominantly in women. We report a case of benign cystic mesothelioma of the peritoneum in an 11-year-old boy. The innumerable cystic lesions that varied in size occupied the entire peritoneal cavity. He underwent two laparotomies in a period of 15 months during which a partial removal of the tumor was performed. Four years after the second operation the child is well and active, despite significant tumor tissue left behind after the first two operations. The management of this disease is discussed, and the importance of a conservative approach minimizing the number of laparotomies and avoiding radical surgical intervention especially in childhood is emphasized.

Entities:  

Mesh:

Year:  1992        PMID: 1734224     DOI: 10.1002/mpo.2950200215

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

Review 1.  Peritoneal cystic mesothelioma treated with minimally invasive approach.

Authors:  G Navarra; S Occhionorelli; M Santini; P Carcoforo; A Sortini; I Donini
Journal:  Surg Endosc       Date:  1996-01       Impact factor: 4.584

Review 2.  Benign multicystic peritoneal mesothelioma: a case report and review of the literature.

Authors:  Michael C Safioleas; Kontzoglou Constantinos; Stamatakos Michael; Giaslakiotis Konstantinos; Safioleas Constantinos; Kostakis Alkiviadis
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

3.  Malignant peritoneal mesothelioma: marked variability of CT findings.

Authors:  T R Smith
Journal:  Abdom Imaging       Date:  1994 Jan-Feb

4.  Benign peritoneal cystic mesothelioma.

Authors:  Jon Arne Søreide; Kjetil Søreide; Hartwig Körner; Håvard Søiland; Ole Jacob Greve; Einar Gudlaugsson
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.